Normal-sized Needles Segment has the Largest Share of Method in the Europe Intradermal Injections Market during 2021–2028
According to our latest study on “Europe Intradermal Injections Market Forecast to 2028 – COVID-19 Impact and Analysis – by Method, Application, and End User,” the market is projected to reach US$ 2,131.1 million by 2028 from US$ 1,029.4 million in 2021; it is expected to grow at a CAGR of 11.0% from 2021 to 2028. The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the increasing prevalence of tuberculosis and allergic reactions along with rising acceptance of intradermal injection in cosmetic surgeries. However, injection site reactions and dossing limitations associated with intradermal injections shall restrict the market growth during the forecast period, to a noticeable extent.
The rising rate of coronavirus results in increased stress on the region's healthcare system, raising the demand for diagnostic tests in its healthcare system, supporting the expansion of the sector in this region. These increasing cases are associated with the increasing demand of essential medicine in Europe, which ultimately improved the demand of drug delivery devices including the intradermal injections. Recently, an intradermal vaccine of Pfizer got approval in Europe for the management of COVID19 and it is believed to trigger the growth rate of intradermal injection market in near future. The intradermal injection market witnessed some shortfall at the beginning of the COVID-19 crisis due to factors such as disruption in supply chain and demand due to lockdown announced by most European countries. Market players and end-user losses their business due to the temporarily shutting down of industries in various regions.
Based on method, the intradermal injections market is segmented into normal-sized needles, short needles, and without needles. In 2020, the normal-sized needles segment accounted for the largest share, short needles segment is expected to grow at the highest CAGR in the forecast period.
BD, West Pharmaceutical Services, Inc., Terumo Corporation, NanoPass, Pharmajet, Idevax, EUNSUNG GLOBAL, Crossject, Cardinal Health Inc., and Hindustan Syringes and Medical Devices Ltd are among the leading companies in the Europe intradermal injections market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
The market for intradermal injections market is segmented into method, application, and end user. Based on method, the Europe intradermal injections market is segmented into normal-sized needles, short needles, and without needles. Based on application, the intradermal injections market is segmented into tuberculin skin test, allergy test, local aesthetics, and others. Based on end user, the intradermal injections market is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. Geographically, the intradermal injections market is segmented into Europe (Germany, UK, France, Spain, Italy, Rest of Europe).
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com